Abstract:// Ke Ma 1, * , Yangwei Fan 1, * , Xuyuan Dong 1 , Danfeng Dong 1 , Yuyan Guo 2 , Xin Wei 3 , Jing Ning 4 , Qianqian Geng 5 , Chuying Wang 1 , Yuan Hu 1 , Mengya Li 1 , Wenxia Niu 1 , Enxiao Li 1 and Yinying Wu 1 1 Department of Medical Oncology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi 710061, P.R. China 2 Department of Medical Radiation Oncology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi 710061, P.R. China 3 Department of Medical Oncology, Shaanxi Province People’s Hospital, Xi’an, Shaanxi 710068, P.R. China 4 Department of Obstetrics and Gynecology, Xi’an Third Hospital, Xi’an, Shaanxi 710068, P.R. China 5 Department of Nuclear Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi 710061, P.R. China * These authors have contributed equally to this work Correspondence to: Yinying Wu, email: shadowless_111@163.com , makeyfly@126.com Enxiao Li, email: doclienxiao@sina.com Keywords: MTA1, metastasis, epithelial to mesenchymal transition, NSCLC, AKT Received: August 10, 2016 Accepted: February 27, 2017 Published: March 21, 2017 ABSTRACT The present study assessed the role of metastasis-associated protein 1 (MTA1) in epithelial to mesenchymal transition (EMT) and metastasis in non-small-cell lung cancer (NSCLC) cells using a normal lung epithelium cell line, three NSCLC cell lines, a mouse NSCLC model, and 56 clinical NSCLC samples. We observed that MTA1 overexpression decreased cellular adhesion, promoted migration and invasion, and changed cytoskeletal polarity. MTA1 knockdown had the opposite effects. MTA1 overexpression decreased E-cadherin, Claudin-1, and ZO-1 levels and increased Vimentin expression in vitro and in vivo , through activation of AKT/GSK3β/β-catenin signaling. However, treatment with the AKT inhibitor MK2206 did not completely rescue effects associated with MTA1 expression changes, indicating that pathways other than the AKT/GSK3β/β-catenin pathway could be involved in MTA1-induced EMT. Compared with normal lung tissues, MTA1 expression was elevated in NSCLC patient tissues and was correlated with American Joint Committee on Cancer stage, T stage, lymphatic metastasis, and patient overall survival. Additionally, MTA1 expression was positively associated with p-AKT and cytoplasmic β-catenin levels. These findings indicate MTA1 promotes NSCLC cell EMT and metastasis via AKT/GSK3β/β-catenin signaling, which suggests MTA1 may be an effective anti-NSCLC therapeutic target.

MTA1, a Novel ATP Synthase Complex Modulator, Enhances Colon Cancer Liver Metastasis by Driving Mitochondrial Metabolism Reprogramming

Silencing Of Atp6v1c1 Prevents Breast Cancer Growth And Bone Metastasis

MTA1 Promotes Epithelial to Mesenchymal Transition and Metastasis in Non-Small-cell Lung Cancer

HIF1A-dependent Overexpression of MTFP1 Promotes Lung Squamous Cell Carcinoma Development by Activating the Glycolysis Pathway

Metastasis-associated protein 1: A potential driver and regulator of the hallmarks of cancer

MTA 1 , an independent prognostic factor , promotes melanoma cell invasion by induction of EMT

MTA1-TJP1 Interaction and Its Involvement in Non-Small Cell Lung Cancer Metastasis

Metabolism-Induced Tumor Activator 1 (Mita1), An Energy Stress-Inducible Long Noncoding Rna, Promotes Hepatocellular Carcinoma Metastasis

Atp6v1c1 Facilitates Breast Cancer Growth and Bone Metastasis through the mTORC1 Pathway

MTAP Deficiency–Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Glycolysis in Pancreatic Cancer

MTA1 is Up-regulated in Colorectal Cancer and is Inversely Correlated with Lymphatic Metastasis.

Supplementary Data from MTAP Deficiency–Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting <i>de Novo</i> Purine Synthesis and Glycolysis in Pancreatic Cancer

Upregulation of MTA1 in Colon Cancer Drives A CD8+ T Cell-Rich But Classical Macrophage-Lacking Immunosuppressive Tumor Microenvironment

Bioinformatic Exploration of Mta1-Regulated Gene Networks in Colon Cancer

MTA1 Promotes Tumorigenesis and Development of Esophageal Squamous Cell Carcinoma Via Activating the MEK/ERK/p90RSK Signaling Pathway

ATP Synthase Ecto-Α-subunit: a Novel Therapeutic Target for Breast Cancer

MTA1 Promotes Metastasis of MPM Via Suppression of E-cadherin

N-myristoyltransferase-1 is necessary for lysosomal degradation and mTORC1 activation in cancer cells

siMTA1-Loaded Exosomes Enhanced Chemotherapeutic Effect of Gemcitabine in Luminal-b Type Breast Cancer by Inhibition of EMT/HIF-α and Autophagy Pathways

Clinicopathological and Prognostic Significance of Metastasis-Associated Protein 1 Expression and Its Correlation with Angiogenesis in Lung Invasive Adenocarcinomas, Based on the 2011 IASLC/ATS/ERS Classification

Unravelling The Complexity And Functions Of Mta Coregulators In Human Cancer